These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33180610)

  • 21. Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner.
    Bell DA; Hooper AJ; Edwards G; Southwell L; Pang J; van Bockxmeer FM; Watts GF; Burnett JR
    Atherosclerosis; 2014 Jun; 234(2):469-72. PubMed ID: 24814411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia.
    Besseling J; Reitsma JB; Gaudet D; Brisson D; Kastelein JJ; Hovingh GK; Hutten BA
    Eur Heart J; 2017 Feb; 38(8):565-573. PubMed ID: 27044878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
    Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
    Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
    Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
    Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan ÜY; Sansoy V
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation screening and genotype:phenotype correlation in familial hypercholesterolaemia.
    Graham CA; McClean E; Ward AJ; Beattie ED; Martin S; O'Kane M; Young IS; Nicholls DP
    Atherosclerosis; 1999 Dec; 147(2):309-16. PubMed ID: 10559517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry.
    Pang J; Sullivan DR; Hare DL; Colquhoun DM; Bates TR; Ryan JDM; Bishop W; Burnett JR; Bell DA; Simons LA; Mirzaee S; Kostner KM; Nestel PJ; Wilson AM; O'Brien RC; Janus ED; Clifton PM; Ardill JJ; Chan DC; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2021 Mar; 30(3):372-379. PubMed ID: 32873489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
    Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
    Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the identification of patients with a genetic diagnosis of familial hypercholesterolaemia in primary care: A strategy to achieve the NHS long term plan.
    Ingoe L; Potter A; Musson S; Neely D; Pilkington G; Allen AJ; Reay D; Luvai A; McAnulty C; Camm N; Berry I; Nichols J; Forbes G; Newton J; Carey PE
    Atherosclerosis; 2021 May; 325():38-45. PubMed ID: 33892327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study.
    Qureshi N; Weng S; Tranter J; El-Kadiki A; Kai J
    BMJ Open; 2016 May; 6(5):e011734. PubMed ID: 27231005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
    Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can patients be accurately assessed for familial hypercholesterolaemia in primary care?
    Bell DA; Kirke AB; Barbour R; Southwell L; Pang J; Burrows S; Watts GF
    Heart Lung Circ; 2014 Dec; 23(12):1153-7. PubMed ID: 25065543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom.
    Heath KE; Humphries SE; Middleton-Price H; Boxer M
    Eur J Hum Genet; 2001 Apr; 9(4):244-52. PubMed ID: 11313767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.